PULMATRIX, INC. Operating Cash Flow
PULMATRIX, INC. (PULM) reported Operating Cash Flow of -$2.17 million for the 6-month period ending 2026-06-30, per its S-4/A filed 2026-09-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-09-17
- PULMATRIX, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$1.11M.
- PULMATRIX, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$1.07M.
- PULMATRIX, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$706.00K.
- PULMATRIX, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$1.03M.
- PULMATRIX, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$15.98M.
- PULMATRIX, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$19.36M.
- PULMATRIX, INC. net cash provided by (used in) operating activities for fiscal 2021 was -$19.73M.
- PULMATRIX, INC. net cash provided by (used in) operating activities for fiscal 2020 was -$12.48M, a 486.47% decline from fiscal 2019.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.11M derived: S-4/A 6 month − S-4/A 3 month · filed 2026-09-17 | -$2.17M S-4/A · filed 2026-09-17 | -$2.88M derived: sum of 3 quarters · filed 2026-09-17 | -$3.91M derived: sum of 4 quarters · filed 2026-09-17 |
| 2026-03-31 | -$1.07M S-4/A · filed 2026-08-03 | -$1.77M derived: sum of 2 quarters · filed 2026-09-17 | -$2.80M derived: sum of 3 quarters · filed 2026-09-17 | -$4.69M derived: sum of 4 quarters · filed 2026-09-17 |
| 2025-12-31 | -$706.00K derived: S-4/A 12 month − 10-Q 9 month · filed 2026-09-17 | -$1.74M derived: sum of 2 quarters · filed 2026-09-17 | -$3.62M derived: sum of 3 quarters · filed 2026-09-17 | -$5.43M S-4/A · filed 2026-09-17 |
| 2025-09-30 | -$1.03M derived: 10-Q 9 month − S-4/A 6 month · filed 2025-10-16 | -$2.91M derived: sum of 2 quarters · filed 2026-09-17 | -$4.73M 10-Q · filed 2025-10-16 | -$5.99M derived: sum of 4 quarters · filed 2026-09-17 |
| 2025-06-30 | -$1.88M derived: S-4/A 6 month − S-4/A 3 month · filed 2026-09-17 | -$3.70M S-4/A · filed 2026-09-17 | -$4.96M derived: sum of 3 quarters · filed 2026-09-17 | -$8.02M derived: sum of 4 quarters · filed 2026-09-17 |
| 2025-03-31 | -$1.81M S-4/A · filed 2026-08-03 | -$3.07M derived: sum of 2 quarters · filed 2026-09-17 | -$6.13M derived: sum of 3 quarters · filed 2026-09-17 | -$9.81M derived: sum of 4 quarters · filed 2026-09-17 |
| 2024-12-31 | -$1.26M derived: S-4/A 12 month − 10-Q 9 month · filed 2026-09-17 | -$4.32M derived: sum of 2 quarters · filed 2026-09-17 | -$8.00M derived: sum of 3 quarters · filed 2026-09-17 | -$10.72M S-4/A · filed 2026-09-17 |
| 2024-09-30 | -$3.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-16 | -$6.74M derived: sum of 2 quarters · filed 2025-10-16 | -$9.46M 10-Q · filed 2025-10-16 | -$11.47M derived: sum of 4 quarters · filed 2025-10-16 |
| 2024-06-30 | -$3.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$6.40M 10-Q · filed 2025-08-06 | -$8.41M derived: sum of 3 quarters · filed 2025-08-06 | -$12.55M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | -$2.72M 10-Q · filed 2025-05-15 | -$4.73M derived: sum of 2 quarters · filed 2025-05-15 | -$8.87M derived: sum of 3 quarters · filed 2025-05-15 | -$13.78M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | -$6.15M derived: sum of 2 quarters · filed 2025-03-21 | -$11.06M derived: sum of 3 quarters · filed 2025-03-21 | -$15.98M 10-K · filed 2025-03-21 |
| 2023-09-30 | -$4.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$9.05M derived: sum of 2 quarters · filed 2024-11-08 | -$13.97M 10-Q · filed 2024-11-08 | -$19.02M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | -$4.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$9.83M 10-Q · filed 2024-08-13 | -$14.88M derived: sum of 3 quarters · filed 2024-08-13 | -$18.48M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$4.93M 10-Q · filed 2024-05-10 | -$9.97M derived: sum of 2 quarters · filed 2024-05-10 | -$13.58M derived: sum of 3 quarters · filed 2024-05-10 | -$18.14M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | -$5.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$8.65M derived: sum of 2 quarters · filed 2024-03-28 | -$13.21M derived: sum of 3 quarters · filed 2024-03-28 | -$19.36M 10-K · filed 2024-03-28 |
| 2022-09-30 | -$3.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$8.17M derived: sum of 2 quarters · filed 2023-11-09 | -$14.31M 10-Q · filed 2023-11-09 | -$18.71M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$4.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$10.71M 10-Q · filed 2023-08-10 | -$15.10M derived: sum of 3 quarters · filed 2023-08-10 | -$18.41M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$6.14M 10-Q · filed 2023-05-12 | -$10.54M derived: sum of 2 quarters · filed 2023-05-12 | -$13.85M derived: sum of 3 quarters · filed 2023-05-12 | -$20.38M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | -$4.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$7.71M derived: sum of 2 quarters · filed 2023-03-30 | -$14.23M derived: sum of 3 quarters · filed 2023-03-30 | -$19.73M 10-K · filed 2023-03-30 |
| 2021-09-30 | -$3.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$9.84M derived: sum of 2 quarters · filed 2022-11-10 | -$15.33M 10-Q · filed 2022-11-10 | -$18.10M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$6.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$12.02M 10-Q · filed 2022-08-10 | -$14.79M derived: sum of 3 quarters · filed 2022-08-10 | -$20.30M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | -$5.50M 10-Q · filed 2022-05-12 | -$8.26M derived: sum of 2 quarters · filed 2022-05-12 | -$13.78M derived: sum of 3 quarters · filed 2022-05-12 | -$18.78M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$2.77M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$8.28M derived: sum of 2 quarters · filed 2022-03-29 | -$13.28M derived: sum of 3 quarters · filed 2022-03-29 | -$12.48M 10-K · filed 2022-03-29 |
| 2020-09-30 | -$5.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$10.51M derived: sum of 2 quarters · filed 2021-11-10 | -$9.71M 10-Q · filed 2021-11-10 | -$14.15M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$4.20M 10-Q · filed 2021-08-10 | -$8.63M derived: sum of 3 quarters · filed 2021-08-10 | -$12.56M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $798.00K 10-Q · filed 2021-05-11 | -$3.63M derived: sum of 2 quarters · filed 2021-05-11 | -$7.56M derived: sum of 3 quarters · filed 2021-05-11 | $7.48M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | -$4.43M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | -$8.36M derived: sum of 2 quarters · filed 2021-03-23 | $6.69M derived: sum of 3 quarters · filed 2021-03-23 | $3.23M 10-K · filed 2021-03-23 |
| 2019-09-30 | -$3.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $11.12M derived: sum of 2 quarters · filed 2020-11-12 | $7.66M 10-Q · filed 2020-11-12 | $3.50M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $15.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $11.59M 10-Q · filed 2020-08-07 | $7.43M derived: sum of 3 quarters · filed 2020-08-07 | $2.90M derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | -$3.46M 10-Q · filed 2020-05-14 | -$7.62M derived: sum of 2 quarters · filed 2020-05-14 | -$12.14M derived: sum of 3 quarters · filed 2020-05-14 | -$17.09M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | -$4.17M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$8.69M derived: sum of 2 quarters · filed 2020-03-26 | -$13.64M derived: sum of 3 quarters · filed 2020-03-26 | -$16.76M 10-K · filed 2020-03-26 |
| 2018-09-30 | -$4.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | -$9.47M derived: sum of 2 quarters · filed 2019-11-01 | -$12.60M 10-Q · filed 2019-11-01 | -$15.81M derived: sum of 4 quarters · filed 2019-11-01 |
| 2018-06-30 | -$4.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | -$8.07M 10-Q · filed 2019-08-05 | -$11.29M derived: sum of 3 quarters · filed 2019-08-05 | -$15.90M derived: sum of 4 quarters · filed 2019-08-05 |
| 2018-03-31 | -$3.13M 10-Q · filed 2019-05-15 | -$6.34M derived: sum of 2 quarters · filed 2019-05-15 | -$10.95M derived: sum of 3 quarters · filed 2019-05-15 | |
| 2017-12-31 | -$3.21M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | -$7.83M derived: sum of 2 quarters · filed 2019-02-19 | -$14.48M 10-K · filed 2019-02-19 | |
| 2017-09-30 | -$4.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$11.27M 10-Q · filed 2018-11-14 | ||
| 2017-06-30 | -$6.65M 10-Q · filed 2018-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |